Market Cap 36.69M
Revenue (ttm) 19.89M
Net Income (ttm) -131.67M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -661.99%
Debt to Equity Ratio 0.00
Volume 19,187
Avg Vol 68,824
Day's Range N/A - N/A
Shares Out 6.74M
Stochastic %K 35%
Beta 2.05
Analysts Sell
Price Target $6.83

Company Profile

Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-dri...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 655 7500
Address:
301 Binney Street, Cambridge, United States
SuperGreenToday
SuperGreenToday Dec. 30 at 10:47 PM
$GBIO Share Price: $5.61 Contract Selected: Jan 16, 2026 $2.5 Calls Buy Zone: $0.03 – $0.04 Target Zone: $0.05 – $0.07 Potential Upside: 66% ROI Time to Expiration: 16 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PortfolioOptimizer
PortfolioOptimizer Dec. 25 at 3:43 PM
$GBIO The setup offers potential, but only if discipline accelerates faster than complexity. Sequential improvement must start appearing across core metrics. Consistent milestones could shift perception faster than fundamentals alone. Absent confirmation, volatility is likely to persist.
0 · Reply
breakeven2
breakeven2 Dec. 23 at 10:08 PM
$GBIO long long time years without one single day ⬆️ 150% or close So stupid managing
1 · Reply
misterbond007
misterbond007 Dec. 20 at 2:03 PM
$RILY $CNTX $GBIO 🏛️🧙🥦
0 · Reply
Wilder992001
Wilder992001 Dec. 18 at 2:39 PM
0 · Reply
JohnTrack
JohnTrack Dec. 17 at 5:36 AM
$GBIO sweet cash deal! https://www.rapidticker.com/news/gbio-sec-filing-19f730
0 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 1:53 PM
Wedbush has adjusted their stance on Generation Bio ( $GBIO ), setting the rating to Outperform with a target price of 7 → 5.5.
0 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 1:09 PM
Jefferies has updated their rating for Generation Bio ( $GBIO ) to Hold with a price target of 5.
0 · Reply
notreload_ai
notreload_ai Dec. 16 at 11:44 AM
Wells Fargo upgrades $GLUE on 2026 catalysts, while Jefferies downgrades $GBIO due to its pending acquisition by $XOMA https://notreload.xyz/wells-fargo-upgrades-glue-jefferies-downgrades-gbio/
0 · Reply
dixiebull
dixiebull Dec. 15 at 11:13 PM
$ARTV nice grind all day making it to 7.25, see if 5 holds for 5.50 and 6 to 6.50 $GBIO could keep going on news, see if 5 holds for 5.50 to 6+ $IMNM spiked to 29.41, see if 22 holds for another move to 25+ $ORGO spike to 6.34, if 5 holds with volume can get 6 and 6.50 $CLYM pushed to 4.82, see if 3.50 holds for 4 break to 4.50 and 5
1 · Reply
Latest News on GBIO
XOMA Royalty Enters into Agreement to Acquire Generation Bio

Dec 15, 2025, 5:00 PM EST - 23 days ago

XOMA Royalty Enters into Agreement to Acquire Generation Bio


Generation Bio Announces Third Quarter 2025 Financial Results

Nov 5, 2025, 4:05 PM EST - 2 months ago

Generation Bio Announces Third Quarter 2025 Financial Results


Generation Bio Announces CEO Transition

Oct 22, 2025, 4:05 PM EDT - 2 months ago

Generation Bio Announces CEO Transition


Generation Bio Announces 1-for-10 Reverse Stock Split

Jul 18, 2025, 8:35 AM EDT - 6 months ago

Generation Bio Announces 1-for-10 Reverse Stock Split


Generation Bio Reports Second Quarter 2023 Financial Results

Aug 2, 2023, 4:15 PM EDT - 2 years ago

Generation Bio Reports Second Quarter 2023 Financial Results


Generation Bio, Moderna announce collaboration

Mar 23, 2023, 7:44 AM EDT - 3 years ago

Generation Bio, Moderna announce collaboration

MRNA


SuperGreenToday
SuperGreenToday Dec. 30 at 10:47 PM
$GBIO Share Price: $5.61 Contract Selected: Jan 16, 2026 $2.5 Calls Buy Zone: $0.03 – $0.04 Target Zone: $0.05 – $0.07 Potential Upside: 66% ROI Time to Expiration: 16 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PortfolioOptimizer
PortfolioOptimizer Dec. 25 at 3:43 PM
$GBIO The setup offers potential, but only if discipline accelerates faster than complexity. Sequential improvement must start appearing across core metrics. Consistent milestones could shift perception faster than fundamentals alone. Absent confirmation, volatility is likely to persist.
0 · Reply
breakeven2
breakeven2 Dec. 23 at 10:08 PM
$GBIO long long time years without one single day ⬆️ 150% or close So stupid managing
1 · Reply
misterbond007
misterbond007 Dec. 20 at 2:03 PM
$RILY $CNTX $GBIO 🏛️🧙🥦
0 · Reply
Wilder992001
Wilder992001 Dec. 18 at 2:39 PM
0 · Reply
JohnTrack
JohnTrack Dec. 17 at 5:36 AM
$GBIO sweet cash deal! https://www.rapidticker.com/news/gbio-sec-filing-19f730
0 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 1:53 PM
Wedbush has adjusted their stance on Generation Bio ( $GBIO ), setting the rating to Outperform with a target price of 7 → 5.5.
0 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 1:09 PM
Jefferies has updated their rating for Generation Bio ( $GBIO ) to Hold with a price target of 5.
0 · Reply
notreload_ai
notreload_ai Dec. 16 at 11:44 AM
Wells Fargo upgrades $GLUE on 2026 catalysts, while Jefferies downgrades $GBIO due to its pending acquisition by $XOMA https://notreload.xyz/wells-fargo-upgrades-glue-jefferies-downgrades-gbio/
0 · Reply
dixiebull
dixiebull Dec. 15 at 11:13 PM
$ARTV nice grind all day making it to 7.25, see if 5 holds for 5.50 and 6 to 6.50 $GBIO could keep going on news, see if 5 holds for 5.50 to 6+ $IMNM spiked to 29.41, see if 22 holds for another move to 25+ $ORGO spike to 6.34, if 5 holds with volume can get 6 and 6.50 $CLYM pushed to 4.82, see if 3.50 holds for 4 break to 4.50 and 5
1 · Reply
TwongStocks
TwongStocks Dec. 15 at 10:10 PM
$GBIO Scheduled to resume at 5:30pm ET.
1 · Reply
JohnTrack
JohnTrack Dec. 15 at 10:04 PM
$GBIO big merger vibes!!! https://www.rapidticker.com/news/gbio-sec-filing-2fe30a
0 · Reply
TwongStocks
TwongStocks Dec. 15 at 10:01 PM
$XOMA Enters into Agreement to Acquire $GBIO https://www.globenewswire.com/news-release/2025/12/15/3205887/0/en/XOMA-Royalty-Enters-into-Agreement-to-Acquire-Generation-Bio.html • $4.2913 per share at the closing of the merger, plus 1 CVR
0 · Reply
TwongStocks
TwongStocks Dec. 15 at 9:59 PM
$GBIO Halted, news pending
0 · Reply
UgoGreg
UgoGreg Nov. 21 at 3:23 PM
$GBIO https://youtu.be/BZgzOxUwjzc
0 · Reply
breakeven2
breakeven2 Nov. 15 at 9:18 AM
$GBIO https://www.sec.gov/Archives/edgar/data/1733294/000200604525000004/xslSCHEDULE_13G_X01/primary_doc.xml
0 · Reply
smartkarma
smartkarma Nov. 11 at 3:09 AM
$GBIO | Strategic Reviews, Mergers, and Financing Updates: Key Developments in Biopharma, Hospitality "Generation Bio (GBIO) is undergoing a strategic review with potential outcomes including liquidation, reverse merger, or sale, with insiders owning 22%." - Special Situation Investments (Special Situation Investments) Read more: https://www.smartkarma.com/insights/strategic-reviews-mergers-and-financing-updates-key-developments-in-biopharma-hospitality
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 9:41 AM
Needham has adjusted their stance on Generation Bio ( $GBIO ), setting the rating to Buy with a target price of 15.
0 · Reply
smartkarma
smartkarma Nov. 10 at 6:18 AM
$GBIO | Generation Bio's Strategic Review: Potential 50% Upside Amid Restructuring and Cash Management Challenges "Generation Bio's net cash is projected at $7.6/share, 50% above the current price, with limited ongoing cash burn." - Special Situation Investments (Special Situation Investments) Read more: https://www.smartkarma.com/insights/generation-bio-s-strategic-review-potential-50-upside-amid-restructuring-and-cash-management-challenges
0 · Reply
breakeven2
breakeven2 Nov. 6 at 8:00 AM
$GBIO No Comments on earnings Q3
0 · Reply
breakeven2
breakeven2 Nov. 4 at 7:25 AM
$GBIO 🙏🏼🙏🏼🙏🏼🙏🏼🙏🏼🙏🏼
0 · Reply
ka1954
ka1954 Oct. 31 at 8:27 PM
$GBIO waiting to end of december or early 2026 now. end of year usually creates tax loss sellers
0 · Reply